Cardiff Oncology, Inc. · NASDAQ:CRDF
BlackRock, Inc. reported a 5.80% stake in Cardiff Oncology, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed Apr 23, 2025
BlackRock, Inc. reported a 5.80% stake in Cardiff Oncology, Inc., 3,841,097 shares, as a passive investor on Mar 31, 2025. Filed Apr 23, 2025 (Schedule 13G).
- Stake
- 5.80%
- Shares
- 3,841,097
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.80% | 3,841,097 |
Source
Related
- Cardiff Oncology, Inc.
- BlackRock, Inc.
- Cardiff Oncology, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Form 4 · Pace Gary W · Jul 16, 2026
- Form 4 · Mohindru Mani · Jul 16, 2026
- Form 4 · Mohindru Mani · Jun 22, 2026
- Form 4 · Pace Gary W · Jun 22, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026